Tech Company Financing Transactions
Metamark Genetics Funding Round
Metamark Genetics closed a $13 million Series B funding round on 11/5/2012. Investors included private investors.
Transaction Overview
Company Name
Announced On
11/5/2012
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Series B
Investors
Proceeds Purpose
The Cambridge Mass.-based firm said proceeds for the Series B round will go toward refinement of its protein-based prostate cancer prognostic tests and the completion of final clinical validation work.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
283 Bear Hill Rd.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Metamark is a privately held oncology company focused on the development of function-based prognostic assays for early staged cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jerry Williamson
Chief Financial Officer
Jonathan Lieber
Chief Medical Officer
Jerome Richie
VP - Operations
Tyler Aldredge
VP - Sales
Britt Oergel
Browse more venture capital transactions:
Prev: 11/5/2012: RingRevenue venture capital transaction
Next: 11/5/2012: Next Step Living venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to record funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs